Professional Documents
Culture Documents
Management of Pain
Acute
Chronic
Somatic
Visceral
Neuropathic
Learning Objectives
(con’t)
Understand the meanings of commonly used terms:
Allodynia
Hyperalgesia
Addiction
Pseudoaddiction
Tolerance
Physical dependence
Learning Objectives
(con’t)
Recommend appropriate pain therapy based upon
guidelines established by the World Health Organization
Select an agent from the appropriate category (Step 1,
Step 2, Step 3) utilizing the following information:
Patient characteristics (renal fx, allergies, etc)
contraindications)
Calculate appropriate conversion doses between
opioids.
Recommend appropriate management of side effects.
Learning Objectives
(con’t)
Secondary Objectives
Explain the pathophysiology involved in pain
patient’s life
Conduct a pain assessment using commonly accepted
tools:
PQRSTU mnemonic
Pain scales
Distraction
Biofeedback
Relaxation
Physical therapy
Chiropractic care
Acupuncture
Introduction
Primary treatment =
Prognosis is
analgesics unpredictable
Can have profound
complications
Treatment is multimodal
Types of Pain (cont.)
Malignant vs Non-malignant
New definition of malignant pain extends to pain
caused by conditions other than cancer, i.e., any
progressive disease that is potentially life limiting
Types of Pain (cont.)
Nociceptive or Neuropathic
Nociceptive pain
Somatic pain: Arises from skin, bone, joint,
muscle or connective tissue
Visceral pain: Arises from internal organs
Neuropathic pain: Caused by nerve damage
Postherpetic neuralgia, trigeminal neuralgia,
diabetic neuropathy
The Language of Pain
Terms Related to Abuse
NSAIDS
ASA
Acetaminophen
Step 2 Products
Pure opioids
+/- anti-inflammatory (step 1)
+/- adjuvant
Morphine
Gold Standard
Used for severe pain
Hepatic metabolism
45% to 55% to morphine-3-glucuronide, which
produces hyperalgesia, allodynia, hyperactivity
10% to 15% to morphine-6-glucuronide, which
has greater analgesic properties, fewer adverse
effects
Codeine
Metabolized to morphine
~10% of patients lack enzyme (CYP2D6) to
convert to morphine and will not experience
analgesia
Causes nausea and constipation more than
other opioids
Hydromorphone
(Dilaudid)
Available only as immediate release
Hydrocodone
Metabolized to hydromorphone
Available only in combinations
Oxymorphone (Opana)
Metabolized to oxymorphone
No more “efficacious” than other products
P’kinetics appear independent of age, renal
statues, or albumin levels
Fentanyl
Potent analgesic
Normeperidine
CNS excitation → seizures (not reversed by
naloxone)
Patients develop tolerance quickly
Should not be used for more than 1 or 2 days
Avoid use in elderly, renal impaired
Methadone
A mainstay of treatment for opioid addiction
Growing use for treating pain
Accumulates with repeated dosing; may require
dosage reduction or increased dosing intervals
Recent FDA advisory regarding QT prolongation
and Torsades de Pointes
An estimated 2,452 overdose deaths were attributed to
methadone in 2003, up from a reported 623 in 1999.
Propoxyphene
Analgesic activity
0.3 mg of parenteral buprenorphine =10 mg of
parenteral morphine
Prescribing restrictions
MDs with special training to use for opioid addiction
outside of a clinic: DEA # starts with “X”.
MDs using for pain do not need “X” in DEA.
Encourage them to write “for pain” on rx.
Buprenorphine (Subutex)
Dosing:
Once daily for addiction
3-4 x daily for pain
Dosage forms:
Injection, solution: 0.3 mg/mL
Tablet, sublingual: Subutex®: 2 mg, 8 mg
Opioids—Drug Selection
Choice of agent based on pain intensity,
pharmacologic factors, coexisting condition,
economic factors
Moderate pain: Combination of opioid and
acetaminophen or an NSAID
Severe pain: Single-agent products
Drug interactions – consider metabolic
pathways
Opioids—Adverse Effects
Methylnaltrexone (Relistor)
Methyl group added to the aine of naltrexone
Increases polarity
Decreases lipid solubility and ability to cross BBB
Humans are unable to demethylate
Approved Use: Opioid-induced constipation
Sub-q dosing according to body weight
Respiratory Depression
Follow up…
The next week, the physician calls you again.
The patient reported to have had much better
relief with the new tablets, but he is still taking
at least 4 lortabs each day.
How would you titrate?
Case #1 (con’t)